These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 39003351)

  • 21. [Biologics. New drugs, new adverse reactions].
    Prinz JC
    Hautarzt; 2010 Aug; 61(8):668-75. PubMed ID: 20585746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis.
    Mourad A; Gniadecki R
    J Rheumatol; 2020 Jan; 47(1):59-65. PubMed ID: 30824641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment.
    Frleta M; Siebert S; McInnes IB
    Curr Rheumatol Rep; 2014 Apr; 16(4):414. PubMed ID: 24570394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
    Gan EY; Chong WS; Tey HL
    BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis.
    D'Adamio S; Silvaggio D; Lombardo P; Bianchi L; Talamonti M; Galluzzo M
    Expert Opin Drug Saf; 2019 Nov; 18(11):1031-1041. PubMed ID: 31479282
    [No Abstract]   [Full Text] [Related]  

  • 26. Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
    Vu TT; Gooderham M; Papp K
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1423-1433. PubMed ID: 27690669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
    Stiff KM; Glines KR; Porter CL; Cline A; Feldman SR
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1209-1218. PubMed ID: 30449211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study.
    De Simone C; Caldarola G; Maiorino A; Tassone F; Campana I; Sollena P; Peris K
    Dermatol Ther; 2016 Sep; 29(5):372-376. PubMed ID: 27146358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Benucci M; Gobbi FL; Guiducci S; Foti R; Mosca M; Goletti D
    Semin Arthritis Rheum; 2017 Oct; 47(2):183-192. PubMed ID: 28413099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis.
    Furue K; Ito T; Furue M
    Cytokine; 2018 Nov; 111():182-188. PubMed ID: 30172115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
    Menter A; Gottlieb A; Feldman SR; Van Voorhees AS; Leonardi CL; Gordon KB; Lebwohl M; Koo JY; Elmets CA; Korman NJ; Beutner KR; Bhushan R
    J Am Acad Dermatol; 2008 May; 58(5):826-50. PubMed ID: 18423260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
    Gossec L; Baraliakos X; Kerschbaumer A; de Wit M; McInnes I; Dougados M; Primdahl J; McGonagle DG; Aletaha D; Balanescu A; Balint PV; Bertheussen H; Boehncke WH; Burmester GR; Canete JD; Damjanov NS; Kragstrup TW; Kvien TK; Landewé RBM; Lories RJU; Marzo-Ortega H; Poddubnyy D; Rodrigues Manica SA; Schett G; Veale DJ; Van den Bosch FE; van der Heijde D; Smolen JS
    Ann Rheum Dis; 2020 Jun; 79(6):700-712. PubMed ID: 32434812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents.
    Shibuya T; Honma M; Iinuma S; Iwasaki T; Takahashi H; Ishida-Yamamoto A
    J Dermatol; 2018 Jun; 45(6):710-714. PubMed ID: 29655215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
    Leonardi CL
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S74-7. PubMed ID: 27551698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging therapies in psoriasis: a systematic review.
    Lee EB; Amin M; Bhutani T; Wu JJ
    Cutis; 2018 Mar; 101(3S):5-9. PubMed ID: 29718027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review of active comparator controlled clinical trials in patients with moderate-to-severe psoriasis.
    No DJ; Amin M; Bhutani T; Wu JJ
    J Dermatolog Treat; 2018 Aug; 29(5):467-474. PubMed ID: 29103334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis.
    Alunno A; Carubbi F; Cafaro G; Pucci G; Battista F; Bartoloni E; Giacomelli R; Schillaci G; Gerli R
    Expert Opin Biol Ther; 2015; 15(12):1727-37. PubMed ID: 26653110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis.
    Li L; Toyama S; Mizuno Y; Yamamoto T; Hiroshima A; Koyama A; Taira H; Sugimoto E; Ito Y; Awaji K; Tateishi S; Kanda H; Asano Y; Sato S; Shibata S
    Sci Rep; 2024 Jul; 14(1):15975. PubMed ID: 38987260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustainability and switching of biologics for psoriasis and psoriatic arthritis at Fukuoka University Psoriasis Registry.
    Bayaraa B; Imafuku S
    J Dermatol; 2019 May; 46(5):389-398. PubMed ID: 30861182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis and the TNF/IL23/IL17 axis.
    Furue K; Ito T; Tsuji G; Kadono T; Furue M
    G Ital Dermatol Venereol; 2019 Aug; 154(4):418-424. PubMed ID: 30648836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.